Page 396 - வாஷிங்டன் பல்கலைக்கழகம் இல் ஸ்டம்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from வாஷிங்டன் பல்கலைக்கழகம் இல் ஸ்டம்ப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In வாஷிங்டன் பல்கலைக்கழகம் இல் ஸ்டம்ப் Today - Breaking & Trending Today

Can a common antidepressant help in the COVID-19 fight?


Early last year, Angela Reiersen, a psychiatrist at Washington University in St. Louis, took ill with what she suspected was COVID-19. Because of a shortage of tests at the time, she never found out for sure, and she recovered before long. But the experience got her thinking about something.
Reiersen had recently seen research suggesting that an antidepressant called fluvoxamine was useful in treating sepsis, a potentially fatal condition in which the body releases a dangerous imbalance of chemicals known as cytokines into the bloodstream in response to an infection.
Might fluvoxamine also be effective in treating COVID-19?
On March 25, Reiersen sent an email to a colleague, Eric Lenze, also a psychiatrist, asking what he thought of her idea. Lenze was equally intrigued. ....

United States , Golden Gate Fields , France General , Los Angeles , Eric Lenze , Nicolas Hoertel , David Seftel , Angela Reiersen , Leigh Turner , Steve Kirsch , Robert Siliciano , Johns Hopkins University , Washington University School , Los Angeles Times , Drug Administration , Paris University , Washington University School Of Medicine , School Of Public Health , Early Treatment Fund , Flu Lab , University Of Minnesota , Skoll Foundation , Early Treatment Fund Advertisement , Harvard Business School Assn , Ami Chiu Washington University , Washington University In St ,

Antidepressant May Help Avoid Serious COVID Illness


Antidepressant May Help Avoid Serious COVID Illness
By Ralph Ellis
Feb. 3, 2021 The anti-depressant Fluvoxamine shows promise in preventing people infected with coronavirus from developing serious symptoms and having to be hospitalized, according to a non-randomized study of California racetrack workers.
What we observed was that all the patients who received Fluvoxamine, none of them had a severe COVID infection that affected their lungs or their respiratory status, Caline Mattar, MD, told KNBC in Los Angeles. Mattar is an infectious disease researcher at Washington University in St. Louis who helped conduct the study that was published in
Open Forum Infectious Diseases. ....

Golden Gate Fields , United States , Los Angeles , Caline Mattar , David Seftel , Washington University , Forum Infectious Diseases , Washington University In St , Open Forum Infectious , Golden Gate Fields Racetrack , Science News , தங்கம் வாயில் புலங்கள் , ஒன்றுபட்டது மாநிலங்களில் , லாஸ் ஏஞ்சல்ஸ் , களின் மேட்டர் , வாஷிங்டன் பல்கலைக்கழகம் , மன்றம் தொற்று நோய்கள் , வாஷிங்டன் பல்கலைக்கழகம் இல் ஸ்டம்ப் , திறந்த மன்றம் தொற்று , தங்கம் வாயில் புலங்கள் ஓட்டப்பந்தயம் , அறிவியல் செய்தி ,